Estados financieros detallados de Delcath Systems, Inc. (DCTH): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Delcath Systems, Inc. registró ingresos de $85.2M en el último ejercicio fiscal, con un CAGR de 5 años del 120.2%.
Márgenes de los últimos 12 meses: margen bruto 87.1%, margen operativo -1.9%, margen neto 0.6%.
Al precio actual de $16.22, DCTH cotiza a un P/E de 1467.87 y un ROE del 0.46%. La capitalización bursátil es de $560M.
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | $2.0M | $2.7M | $3.4M | $1.6M | $1.6M | $3.6M | $2.7M | $2.1M | $37.2M | $85.2M |
| Coste de Ventas | $550000 | $701000 | $1.0M | $719000 | $640000 | $671000 | $686000 | $635000 | $6.2M | $11.8M |
| Beneficio Bruto | $1.4M | $2.0M | $2.4M | $861000 | $1.0M | $2.9M | $2.0M | $1.4M | $31.0M | $73.4M |
| I+D | $8.4M | $10.5M | $19.6M | $9.5M | $11.2M | $13.8M | $18.6M | $17.5M | $13.9M | $29.2M |
| Generales y Administrativos | $9.4M | $9.7M | $9.8M | $11.3M | $11.1M | $13.6M | $17.3M | $22.1M | $29.6M | $43.5M |
| Gastos Operativos | $17.9M | $20.2M | $29.5M | $20.8M | $22.3M | $27.4M | $35.9M | $39.6M | $43.4M | $72.8M |
| Beneficio Operativo | -$16.4M | -$18.2M | -$27.1M | -$19.9M | -$21.3M | -$24.5M | -$33.9M | -$38.2M | -$12.4M | $660000 |
| EBITDA | -$3.3M | -$23.1M | -$10.8M | -$3.9M | -$23.8M | -$24.3M | -$33.7M | -$45.8M | -$26.2M | $3.9M |
| Gastos por Intereses | $14.3M | $21.7M | $8.0M | $4.7M | $175000 | $1.2M | $2.7M | $1.4M | 0 | 0 |
| Beneficio Antes de Impuestos | -$18.0M | -$45.1M | -$19.2M | -$8.9M | -$24.2M | -$25.6M | -$36.5M | -$47.7M | -$26.4M | $3.5M |
| Impuestos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $810000 |
| Beneficio Neto | -$18.0M | -$45.1M | -$19.2M | -$8.9M | -$24.2M | -$25.6M | -$36.5M | -$47.7M | -$26.4M | $2.7M |
| BPA | $-452622931118.73 | $-2275919775.64 | $-503846.14 | $-342.82 | $-8.36 | $-3.59 | $-4.12 | $-0.48 | $-0.11 | $0.08 |
| BPA Diluido | $-452622931118.73 | $-2275919775.64 | $-503846.14 | $-342.82 | $-8.36 | $-3.59 | $-4.12 | $-0.48 | $-0.12 | $0.07 |
| Acciones en Circulación (Diluidas) | $0 | $0 | $38 | $25900 | $2.9M | $7.1M | $8.9M | $16.2M | $28.5M | $39.9M |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $4.4M | $4.0M | $2.5M | $10.0M | $28.6M | $22.8M | $7.7M | $12.6M | $32.4M | $43.5M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $19.8M | $20.8M | $47.6M |
| Cuentas por Cobrar | $403000 | $317000 | $1.2M | $21000 | $57000 | $44000 | $366000 | $483000 | $11.1M | $12.9M |
| Inventario | $660000 | $1.2M | $858000 | $654000 | $855000 | $1.4M | $2.0M | $3.3M | $6.9M | $10.3M |
| Activos Corrientes | $34.2M | $7.6M | $5.9M | $12.6M | $32.3M | $31.2M | $16.2M | $37.2M | $73.8M | $119.5M |
| Inmovilizado Material | $1.1M | $1.3M | $925000 | $1.6M | $2.3M | $2.0M | $1.7M | $1.5M | $2.8M | $4.1M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $35.2M | $8.9M | $6.8M | $14.2M | $34.6M | $33.1M | $17.9M | $38.6M | $76.6M | $123.6M |
| Cuentas por Pagar | $594000 | $3.8M | $7.7M | $4.5M | $1.8M | $638000 | $2.0M | $1.0M | $961000 | $2.7M |
| Deuda a Corto | $13.3M | 0 | $2.0M | 0 | $2.0M | $621000 | $7.8M | $10.2M | 0 | 0 |
| Pasivos Corrientes | $36.1M | $7.8M | $17.8M | $16.0M | $10.0M | $6.0M | $14.7M | $16.4M | $6.1M | $10.9M |
| Deuda a Largo | 0 | 0 | 0 | $2.0M | 0 | $15.0M | $7.8M | 0 | 0 | 0 |
| Pasivos Totales | $36.7M | $8.2M | $21.8M | $20.6M | $12.6M | $21.2M | $23.7M | $22.8M | $7.8M | $12.4M |
| Reservas | -$279.2M | -$324.8M | -$344.1M | -$371.2M | -$395.3M | -$421.0M | -$457.5M | -$505.2M | -$531.5M | -$528.8M |
| Patrimonio Neto | -$1.5M | $678000 | -$14.9M | -$6.4M | $22.1M | $12.0M | -$5.9M | $15.8M | $68.7M | $111.2M |
| Deuda Total | $13.3M | 0 | $2.0M | $2.9M | $2.9M | $16.3M | $15.9M | $10.2M | $1.0M | $936000 |
| Deuda Neta | $8.9M | -$4.0M | -$478000 | -$7.1M | -$25.6M | -$6.5M | $8.2M | -$22.3M | -$52.2M | -$90.1M |
| Capital Circulante | -$1.9M | -$225000 | -$11.8M | -$3.4M | $22.3M | $25.2M | $1.4M | $20.7M | $67.6M | $108.6M |
Flujo de Caja (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Beneficio Neto | -$18.0M | -$45.1M | -$19.2M | -$8.9M | -$24.2M | -$25.6M | -$36.5M | -$47.7M | -$26.4M | $2.7M |
| Amortizaciones | $305000 | $310000 | $444000 | $249000 | $192000 | $146000 | $132000 | $128000 | $229000 | $349000 |
| Compensación en Acciones | $427000 | $129000 | $58000 | $277000 | $3.9M | $7.8M | $7.9M | $8.2M | $9.8M | $24.2M |
| Cambio en Capital Circulante | $1.5M | $2.5M | $11.8M | -$5.6M | -$5.8M | -$5.8M | $2.1M | -$906000 | -$15.5M | -$3.1M |
| Flujo de Caja Operativo | -$14.2M | -$15.4M | -$14.7M | -$23.7M | -$22.9M | -$22.6M | -$24.9M | -$31.3M | -$18.7M | $22.5M |
| Inversiones (CapEx) | -$258000 | -$524000 | -$76000 | -$24000 | -$782000 | -$143000 | -$209000 | -$58000 | -$559000 | -$1.5M |
| Adquisiciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Recompra de Acciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -$6.0M |
| Dividendos Pagados | 0 | -$527000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$14.5M | -$15.9M | -$14.8M | -$23.7M | -$23.6M | -$22.7M | -$25.2M | -$31.3M | -$19.2M | $21.0M |
Crecimiento y Márgenes (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Crecimiento Ingresos (anual) | +36.3% | +25.5% | -53.6% | +4.2% | +116.0% | -23.5% | -24.1% | +1701.7% | +129.1% | |
| Crecimiento Beneficio Neto (anual) | -151.1% | +57.4% | +53.8% | -172.1% | -6.2% | -42.3% | -30.6% | +44.7% | +110.2% | |
| Crecimiento BPA (anual) | +99.5% | +100.0% | +99.9% | +97.6% | +57.0% | -14.7% | +88.2% | +78.1% | +175.5% | |
| Cambio en Acciones (anual) | +144738.1% | +190127.8% | +67789.0% | +11088.5% | +146.6% | +24.1% | +83.1% | +75.7% | +40.0% | |
| Crecimiento FCF (anual) | -10.0% | +7.0% | -60.1% | +0.3% | +3.8% | -10.6% | -24.4% | +38.5% | +209.0% | |
| Margen Bruto | 72.4% | 74.2% | 70.4% | 54.5% | 61.1% | 81.1% | 74.8% | 69.2% | 83.4% | 86.2% |
| Margen Operativo | -825.3% | -669.1% | -794.6% | -1260.0% | -1294.2% | -690.0% | -1245.1% | -1849.0% | -33.4% | 0.8% |
| Margen EBITDA | -167.6% | -851.0% | -317.6% | -245.8% | -1446.8% | -684.0% | -1239.1% | -2219.9% | -70.3% | 4.5% |
| Margen Neto | -902.2% | -1661.8% | -564.2% | -562.0% | -1467.6% | -721.5% | -1342.7% | -2308.9% | -70.9% | 3.2% |
| Margen FCF | -726.5% | -586.4% | -434.6% | -1500.8% | -1436.8% | -639.9% | -925.3% | -1516.2% | -51.7% | 24.6% |
| Tasa Impositiva Efectiva | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | 23.1% |
Datos por Acción (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| FCF por Acción | $-1045092225613.35 | $-793909268.86 | $-388146.58 | $-915.56 | $-8.16 | $-3.18 | $-2.84 | $-1.93 | $-0.67 | $0.53 |
| Dividendo por Acción | $0.00 | $26277489.30 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $0 | $0 | $38 | $25900 | $2.9M | $7.1M | $8.9M | $16.2M | $28.5M | $35.8M |
Qué mirar en Salud / Farma
El pipeline de I+D es el activo invisible. Patentes que caducan = ingresos que evaporan. Mira innovación y flujo de caja.
- I+D / Ingresos — Indica inversión en pipeline futuro. Farma seria reinvierte 15-20%
- Crecimiento EPS 5y — Tras caducidad de patentes, ¿siguen creciendo?
- Margen bruto — Farma de marca >70%. Genéricos mucho más bajo — define el tipo de negocio
- FCF / Net Income — Calidad del beneficio — farma grande debería convertir >90%
- ROIC — Capital reinvertido con eficiencia — clave en farma por ciclos de I+D largos
- Deuda neta / EBITDA — Adquisiciones de farma generan mucha deuda — ojo al post-M&A
- P/E vs historial 10y propio — La mejor comparación es con su propia historia, no con competidores
Rentabilidad
| Rentabilidad sobre capital | 0.46% |
| Rentabilidad sobre capital invertido | -0.60% |
| Rentabilidad sobre activos | 0.39% |
| Margen bruto | 87.05% |
| Margen operativo | -1.90% |
| Margen neto | 0.56% |
Salud financiera
| Deuda / Patrimonio | 0.02 |
| Ratio corriente | 9.83 |
Ratios Clave (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| P/E | -0.00 | -0.00 | -0.00 | -0.06 | -2.14 | -2.16 | -0.87 | -8.58 | -113.58 | 126.25 |
| P/VC | -0.00 | 0.00 | -0.00 | -0.09 | 2.35 | 4.63 | -5.45 | 4.28 | 4.99 | 3.25 |
| P/V | 0.00 | 0.00 | 0.00 | 0.35 | 31.55 | 15.58 | 11.74 | 32.70 | 9.23 | 4.24 |
| Margen Bruto | 72.4% | 74.2% | 70.4% | 54.5% | 61.1% | 81.1% | 74.8% | 69.2% | 83.4% | 86.2% |
| Margen Operativo | -825.3% | -669.1% | -794.6% | -1260.0% | -1294.2% | -690.0% | -1245.1% | -1849.0% | -33.4% | 0.8% |
| Margen Neto | -902.2% | -1661.8% | -564.2% | -562.0% | -1467.6% | -721.5% | -1342.7% | -2308.9% | -70.9% | 3.2% |
Empresas relacionadas: AGL · BWAY · CERS · MASS · NAKA · NPCE · RXST
Explorar sector: Healthcare · Medical - Devices
Más secciones de DCTH: Resumen · Valoración · Estadísticas · Estimaciones · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones